Financial Assistance

Oncology Associates of West Kentucky employs a full-time Patient Navigator. This free service was created to assist patients with any questions they might have about the healthcare system and to address any financial needs they may have. According to the December 2014 issue of Oncology Practice Management, it is estimated that 40% of all Americans, and 66% of the elderly population report having difficulty paying for medications. This financial strain will often cause patients to not fill or reduce their doses of medication. We feel this is unacceptable and have created this position to address this problem so no patient goes without.

There are many programs that we utilize to assist patients every day. Whether you are receiving a service in the outpatient setting, or needing prescription, there is most likely a foundation or financial assistance available for you. Below is a list of Foundations, Nonprofit Organizations, and Manufacturer Patient Assistance Programs that we commonly use. However, we occasionally may access programs not listed below.

If you do choose to participate in an assistance program, you may be required to submit proof of income such as your tax return from the previous year.


Foundations and Nonprofit Organizations

American Cancer Society


Chronic Disease Fund

Healthwell Foundation

Patient Access Network Foundation

Patient Advocate Foundation Co-Pay Relief Program


Manufacture Patient Assistance Programs

Abbvie Inc

  • Lupaneta Pack (leuprolide acetate and norethindrone acetate)
  • Lupron Depot (leuprolide acetate for depot suspension)

Amgen Inc

  • Aranesp (darbepoetin alfa)
  • Epogen (epoetin alfa)
  • Neulasta (pegfilgrastim)
  • Neupogen (filgrastim)
  • Nplate (romiplostim)
  • Prolia (denosumab)
  • Sensipar (cinacalcet)
  • Vectibix (panitumumab)
  • Xgeva (denosumab)

Astellas Pharma Us, Inc / Medivation, Inc

  • Xtandi (enzalutamide)


  • Arimidex (anastrozole)
  • Faslodex (fulvestrant)

Bayer Healthcare Pharmaceuticals Inc

  • Nexavar (sorafenib)
  • Stivarga (regorafebin)

Boehringer Ingelheim Pharmaceuticals, Inc

  • Gilotrif (afatinib)

Bristol-Myers Squibb Company

  • Droxia (hydroxyurea)
  • Erbitux (cetuximab)
  • Ixempra (isabepilone)
  • Opdivo (nivolumab)
  • Sprycel (dasatinib)
  • Yervoy (ipilimumab)

Celgene Corporation

  • Abraxane (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)
  • Istodax (romidepsin)
  • Pomalyst (pomalidomide)
  • Revlimid (lenalidomide)
  • Thalomid (thalidomide)
  • Vidaza (azacitidine)

Eisai Inc

  • Akynzeo (netupitant/palosetron)
  • Aloxi (palosetron hydrochloride injection)
  • Halaven (eribulin mesylate)

Eli Lilly and Company

  • Alimta (pemetrexed)
  • Cyramza (ramucirumab)

Genetech, Inc

  • Avastin (bevacizumab)
  • Gazyva (vismodegib)
  • Herceptin (trastuzumab)
  • Kadcyla (ado-tratuzumab)
  • Perjeta (pertuzumab)
  • Rituxan (rituximab)
  • Tarceva (erlotibib)


  • Tykerb
  • Votrient

Incyte Corporation

  • Jakafi (ruxolitinib)

Janssen Biotech, Inc

  • Procrit (epoetin alfa)
  • Zytiga (abiraterone acetate)

Merck & Co., Inc

  • Emend (fosaprepitant dimeglumine)
  • Keytruda (pembrolizumab)
  • Temodar (temozolomide)

Novartis Pharmaceutical Corporation

  • Afinitor (everolimus)
  • Exjade (deferasirox)
  • Sandostatin LAR Depot (octreotide acetate for injectable suspension)
  • Tasigna (nilotinib)

Pfizer Inc

  • Bosulif(bosutinib)
  • Ibrance (palbociclib)
  • Inlyta (axitinib)
  • Sutent (sunitibib malate)
  • Torisel (temsirolimus)

Pharmacyclics, Inc

  • Imbruvica (ibrutinib

Sanofi-Aventis US

  • Jevtana (cabazitaxel)
  • Leukine (sargramostim)

Teva Pharmaceutical Industries

  • Synribo (omacetaxine mepesuccinate)
  • Treanda (bendamustine HCl)

Government Program

Extra Help (Social Security Administration)